Evidence map›Paper›PMID 30592383›Full record

Observational studyArthritis & rheumatology (Hoboken, N.J.)2019

Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study.

E H Pieter van Dijkhuizen, Federica Del Chierico, Clara Malattia, Alessandra Russo, Denise Pires Marafon, Nienke M Ter Haar, Silvia Magni-Manzoni, Sebastiaan J Vastert, Bruno Dallapiccola, Berent Prakken and 4 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Arthritis & rheumatology (Hoboken, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. The gut-joint axis in juvenile idiopathic arthritis.Arthritis research & therapy · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Highlights on the Contribution of Gut Microbiota to Immune-Mediated Diseases in Childhood.Mediterranean journal of hematology and infectious diseases · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

E H Pieter van DijkhuizenIstituto Giannina Gaslini, Genoa, Italy, and University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Federica Del ChiericoOspedale Pediatrico Bambino Gesù, Rome, Italy.
Clara MalattiaIstituto Giannina Gaslini and Università degli Studi di Genoa, Genoa, Italy.
Alessandra RussoOspedale Pediatrico Bambino Gesù, Rome, Italy.
Denise Pires MarafonOspedale Pediatrico Bambino Gesù, Rome, Italy.
Nienke M Ter HaarUniversity Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Silvia Magni-ManzoniOspedale Pediatrico Bambino Gesù, Rome, Italy.
Sebastiaan J VastertUniversity Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Bruno DallapiccolaOspedale Pediatrico Bambino Gesù, Rome, Italy.
Berent PrakkenUniversity Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Alberto MartiniIstituto Giannina Gaslini and Università degli Studi di Genoa, Genoa, Italy.
Fabrizio De BenedettiOspedale Pediatrico Bambino Gesù, Rome, Italy.
Lorenza PutignaniOspedale Pediatrico Bambino Gesù, Rome, Italy.
Model Driven Paediatric European Digital Repository Consortium
Bambino Gesù Children's Hospital · ITWilhelmina Children's Hospital · NLIstituto Giannina Gaslini · ITUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the composition of gut microbiota in Italian and Dutch patients with juvenile idiopathic arthritis (JIA) at baseline, with inactive disease, and with persistent activity compared to healthy controls.

methodsIn a multicenter, prospective, observational cohort study, fecal samples were collected at baseline from 78 Italian and 21 Dutch treatment-naive JIA patients with <6 months of disease duration and compared to 107 geographically matched samples from healthy children. Forty-four follow-up samples from patients with inactive disease and 25 follow-up samples from patients with persistent activity were analyzed. Gut microbiota composition was determined by 16S ribosomal RNA-based metagenomics. Alpha- and β-diversity were computed, and log ratios of relative abundance were compared between patients and healthy controls using random forest models and logistic regression.

resultsBaseline samples from Italian patients showed reduced richness compared to healthy controls (P < 0.001). Random forest models distinguished between Italian patient baseline samples and healthy controls and suggested differences between Dutch patient samples and healthy controls (areas under the curve >0.99 and 0.71, respectively). The operational taxonomic units (OTUs) of Erysipelotrichaceae (increased in patients), Allobaculum (decreased in patients), and Faecalibacterium prausnitzii (increased in patients) showed different relative abundance in Italian patient baseline samples compared to controls after controlling for multiple comparisons. Some OTUs differed between Dutch patient samples and healthy controls, but no evidence remained after controlling for multiple comparisons. No differences were found in paired analysis between Italian patient baseline and inactive disease samples.

conclusionOur findings show evidence for dysbiosis in JIA patients. Only patient/control status, age, and geographic origin appear to be drivers of the microbiota profiles, regardless of disease activity stage, inflammation, and markers of autoimmunity.

Indexed as

Arthritis, JuvenileBacillotaCase-Control StudiesChildChild, PreschoolCohort StudiesComorbidityDysbiosisFaecalibacterium prausnitziiFemaleGastrointestinal MicrobiomeHumansItalyLogistic ModelsLongitudinal StudiesMaleRNA, Ribosomal, 16S

Identifiers

PMID30592383
PMCPMC6593809
OpenAlexW2907698625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.